Clinical Trials Directory

Trials / Completed

CompletedNCT06762613

Functional Innovation and Application Research of Domestic Advanced Low-Dose DSA/CT-DSA

Enhancing CBCT-Guided Lung Nodule Puncture Efficiency With Generative AI

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
220 (actual)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if Generative AI Based Puncture Surgery Navigation System (GPS) can guide lung puncture in adults better. It will also learn about the quality improvement of cone beam CT (CBCT) by GPS. The main questions it aims to answer are: * Does GPS lower the number of punctures, radiation dose, and complications of participants undergo percutaneous lung puncture? * Does GPS improve the quality of CBCT images? Researchers will compare GPS to a conventional CBCT guided percutaneous lung puncture to see if GPS can improve the efficacy of lung puncture. Participants will: * Take the percutaneous lung puncture by the guidance of GPS or conventional CBCT (placebo) * The number of punctures, the success rate of the procedure, the radiation dose, intraoperative complications and postoperative complications at 7 days will be recorded * The images of CBCT will be collected

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTGenerative AI Based Puncture Surgery Navigation SystemParticipants will receive percutaneous lung puncture under the guidance of GPS.
DEVICECone beam CTParticipants will receive percutaneous lung puncture under the guidance of cone beam CT.

Timeline

Start date
2025-01-01
Primary completion
2025-03-31
Completion
2025-06-18
First posted
2025-01-07
Last updated
2025-07-23

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06762613. Inclusion in this directory is not an endorsement.

Functional Innovation and Application Research of Domestic Advanced Low-Dose DSA/CT-DSA (NCT06762613) · Clinical Trials Directory